{"id":"W2254789682","doi":"10.1155/2002/493296","title":"The Addition of Salmeterol 50 µg Bid to Anticholinergenic Treatment in Patients with COPD: A Randomized Placebo Controlled Trial","year":2002,"lang":"en","type":"article","venue":"Canadian Respiratory Journal","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital","funders":"GlaxoSmithKline","keywords":"Salmeterol; Medicine; COPD; Placebo; Anticholinergic; Bronchodilator; Randomized controlled trial; Anesthesia; Internal medicine; Asthma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00200477,0.00155791,0.004672186,0.0007793702,0.0005884307,0.001366879,0.001204769,0.003127761,0.008136576],"category_scores_gemma":[0.002383575,0.0009712753,0.002492554,0.0006613724,0.001780649,0.001120814,0.0005800223,0.003012813,0.001190399],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007837165,"about_ca_system_score_gemma":0.001364059,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001130692,"about_ca_topic_score_gemma":0.001884347,"domain_scores_codex":[0.9989144,0.0005896931,0.0001111852,0.0001809518,0.00008428805,0.0001195332],"domain_scores_gemma":[0.9986479,0.0005209883,0.0003253128,0.00007678264,0.00007613957,0.0003528507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9898775,0.002046404,0.0001827081,0.0008143666,0.0004760739,0.00002314135,0.00002103117,0.00006796862,0.000640478,0.00003629822,0.000244394,0.005569632],"study_design_scores_gemma":[0.9832147,0.01575637,0.0003994474,0.00003430609,0.000238213,0.000009051946,0.000008840057,0.00008967565,0.00006580135,0.00003011135,0.0001484822,0.000005124255],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9665017,0.01872871,0.0007301943,0.001797857,0.00255211,0.005904069,0.001025651,0.0002539054,0.00250572],"genre_scores_gemma":[0.9707747,0.01079318,0.001978467,0.002353908,0.001698436,0.007930287,0.000894545,0.00002872282,0.003547749],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9988693,"threshold_uncertainty_score":0.02721953,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0183407024204525,"score_gpt":0.2638323017331758,"score_spread":0.2454915993127234,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}